← All trials
NCT06754384
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 30, 2025
- Primary completion
- Jan 30, 2026
- Completion date
- Aug 30, 2026
- First posted
- Dec 31, 2024
- Last posted
- Jan 1, 2025
- Enrollment
- 552
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sinovac Biotech Co., LtdLead sponsor
- Government of ChinaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.